281 related articles for article (PubMed ID: 36348665)
1. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract][Full Text] [Related]
2. Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang Z; Chen P; Xie H; Cao P
Cancer Med; 2020 Feb; 9(4):1349-1364. PubMed ID: 31876977
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of circulating tumor DNA in hepatitis B virus induced hepatocellular carcinoma: a systematic review and meta-analysis.
Chang Y; Jeong SW; Jang JY; Eun H; Lee YS; Song DS; Yu SJ; Lee SH; Kim W; Lee HW; Kim SG; Ryu S; Park S
J Liver Cancer; 2022 Sep; 22(2):167-177. PubMed ID: 37383408
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
Zhang J; Zhao Y; Yang Q
Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
[TBL] [Abstract][Full Text] [Related]
5. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.
Liao W; Mao Y; Ge P; Yang H; Xu H; Lu X; Sang X; Zhong S
Medicine (Baltimore); 2015 Apr; 94(14):e722. PubMed ID: 25860220
[TBL] [Abstract][Full Text] [Related]
6. Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis.
Min L; Chen J; Yu M; Liu D
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675337
[TBL] [Abstract][Full Text] [Related]
7. Is Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging an Accurate Diagnostic Method for Hepatocellular Carcinoma? A Systematic Review with Meta-Analysis.
Yinzhong W; Xiaoxue T; Jinhui T; Pengcheng Y; Xiaoying L; Junqiang L
Curr Med Imaging; 2022; 18(6):633-647. PubMed ID: 34533447
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis: the diagnostic accuracy of methylated
Chandrapalan S; Bannaga A; Weidner A; Hitchins MP; Arasaradnam RP
Scand J Gastroenterol; 2022 Apr; 57(4):473-480. PubMed ID: 34957898
[TBL] [Abstract][Full Text] [Related]
9. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M
Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434
[TBL] [Abstract][Full Text] [Related]
11. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
[TBL] [Abstract][Full Text] [Related]
12. Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis.
Zhao ZH; Fan YC; Yang Y; Wang K
World J Gastroenterol; 2013 Nov; 19(41):7189-96. PubMed ID: 24222965
[TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: An updated meta-analysis.
Li Z; Mou L; Gao H; Zeng Y; Tang X; Deng X; Pu Z; Ni Y; Zhan Y
Medicine (Baltimore); 2019 Aug; 98(32):e16725. PubMed ID: 31393380
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma.
Fu J; Li Y; Li Z; Li N
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29717027
[TBL] [Abstract][Full Text] [Related]
16. AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis.
Zhou JM; Wang T; Zhang KH
Medicine (Baltimore); 2021 Oct; 100(43):e27673. PubMed ID: 34713864
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels.
Xu WJ; Guo BL; Han YG; Shi L; Ma WS
Tumour Biol; 2014 Dec; 35(12):12069-74. PubMed ID: 25209179
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of clusterin in hepatocellular carcinoma: A meta-analysis.
Gao G; Luan X
Int J Biol Markers; 2022 Dec; 37(4):404-411. PubMed ID: 35645149
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis.
Huang Y; Chen Y; Tu S; Zhang J; Qiu Y; Yu W
BMC Infect Dis; 2022 Apr; 22(1):323. PubMed ID: 35365115
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis.
Li Y; Chen P; Chen Z
Transl Cancer Res; 2021 May; 10(5):2265-2276. PubMed ID: 35116544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
